Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Third member of FDA expert panel exits amid Alzheimer's drug flap
The FDA's controversial decision to approve Biogen and Eisai's Alzheimer's disease treatment Aduhelm (aducanumab) has prompted a third member to resign from the advisory committee ...
EU Adds Another Rare Blood Condition as Side Effect of AstraZeneca Shot
(Reuters) -Europe's drug regulator on Friday identified another very rare blood condition as a potential side effect of AstraZeneca's COVID-19 vaccine and said it was looking into case...
Research identifies potential antiviral compound for COVID-19, flu, different viral an infection
UMass Medical School scientists Katherine A.
Astellas’ Xtandi bags NICE approval in prostate cancer
Astellas’ oral treatment Xtandi has received approval from the National Institute for Health and Care Excellence (NICE) for the treatment of metastatic hormone-sensitive prostate cancer (...
Bayer subsidiary doses first patient with Parkinson’s disease cell therapy
German pharma company Bayer has announced that it has made progress in its ‘two-pronged’ approach to deliver cell and gene therapy candidates for the treatment of Parkinson’s disease.
Pandemic inevitably slows pharma M&A activity but appetite for deals remains
The initial outbreak of the COVID-19 pandemic delayed merger and acquisitions in the pharma sector, but evidence points to an uptick in activity because the rationale for sealing deals hasn’t change...
Biogen grilled on hefty Alzheimer's drug price
A day after the FDA's landmark decision to grant accelerated approval to Biogen's Alzheimer's disease drug Aduhelm (aducanumab), company executives on Tuesday were asked to explain...
With $1.2B deal for molnupiravir, U.S. bets on Merck's oral COVID-19 antiviral
Merck has struggled to develop therapeutics and vaccines to fight COVID-19.
EmpowerPharm becomes the first Canadian pharmaceutical company with a certified GMP facility fully dedicated to manufacture CBD tablets and capsules
BURLINGTON, ON.
On a vaccine roll, Pfizer scores FDA nod for Prevnar 13 follow-up ahead of rival Merck
Another year, another major vaccine approval for Pfizer.
AstraZeneca takes PARP battle to court, seeking a larger claim to GSK's key cancer med Zejula: report
GlaxoSmithKline’s $5.
For first time since 2014, FDA approves new drug for chronic weight management
Friday, the FDA approved a drug treatment for chronic weight management for the first time since 2014.
244
245
246
247
248
249
250
251
252
